1. Home
  2. NVNO vs OPHC Comparison

NVNO vs OPHC Comparison

Compare NVNO & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • OPHC
  • Stock Information
  • Founded
  • NVNO 1987
  • OPHC 2000
  • Country
  • NVNO United States
  • OPHC United States
  • Employees
  • NVNO N/A
  • OPHC N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • OPHC Major Banks
  • Sector
  • NVNO Health Care
  • OPHC Finance
  • Exchange
  • NVNO Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • NVNO 41.0M
  • OPHC 43.1M
  • IPO Year
  • NVNO N/A
  • OPHC N/A
  • Fundamental
  • Price
  • NVNO $3.65
  • OPHC $4.61
  • Analyst Decision
  • NVNO
  • OPHC Hold
  • Analyst Count
  • NVNO 0
  • OPHC 1
  • Target Price
  • NVNO N/A
  • OPHC $5.25
  • AVG Volume (30 Days)
  • NVNO 76.7K
  • OPHC 15.7K
  • Earning Date
  • NVNO 05-01-2025
  • OPHC 05-20-2025
  • Dividend Yield
  • NVNO N/A
  • OPHC N/A
  • EPS Growth
  • NVNO N/A
  • OPHC 53.23
  • EPS
  • NVNO N/A
  • OPHC 1.33
  • Revenue
  • NVNO N/A
  • OPHC $37,091,000.00
  • Revenue This Year
  • NVNO N/A
  • OPHC N/A
  • Revenue Next Year
  • NVNO $409.09
  • OPHC N/A
  • P/E Ratio
  • NVNO N/A
  • OPHC $3.44
  • Revenue Growth
  • NVNO N/A
  • OPHC 60.44
  • 52 Week Low
  • NVNO $2.03
  • OPHC $3.53
  • 52 Week High
  • NVNO $6.48
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 71.64
  • OPHC 72.33
  • Support Level
  • NVNO $2.61
  • OPHC $4.20
  • Resistance Level
  • NVNO $3.97
  • OPHC $4.51
  • Average True Range (ATR)
  • NVNO 0.22
  • OPHC 0.12
  • MACD
  • NVNO 0.11
  • OPHC 0.05
  • Stochastic Oscillator
  • NVNO 80.00
  • OPHC 97.73

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: